Literature DB >> 7504578

Casodex--mechanisms of action and opportunities for usage.

G Blackledge1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504578     DOI: 10.1002/1097-0142(19931215)72:12+<3830::aid-cncr2820721713>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer.

Authors:  Di Wen; Deepak Chitkara; Hao Wu; Michael Danquah; Renukadevi Patil; Duane D Miller; Ram I Mahato
Journal:  Pharm Res       Date:  2014-05-02       Impact factor: 4.200

Review 2.  Bicalutamide: clinical pharmacokinetics and metabolism.

Authors:  Ian D Cockshott
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Micellar delivery of bicalutamide and embelin for treating prostate cancer.

Authors:  Michael Danquah; Feng Li; Charles B Duke; Duane D Miller; Ram I Mahato
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.